View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AV18 | Publication ID: Spring 2023 |
Title: Hospital Outpatient Prospective Payment System: Remedy for 340B-Acquired Drugs Purchased in Cost Years 2018-2022 (CMS-1793) | |
Abstract:
In response to the Supreme Court decision in American Hospital Association v. Becerra, 142 S. Ct. 1896 (2022), CMS will issue a notice of proposed rulemaking regarding potential remedies affecting cost years 2018-2022. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: Yes | Unfunded Mandates: No |
CFR Citation: Not Yet Determined (To search for a specific CFR, visit the Code of Federal Regulations.) | |
Legal Authority: 42 U.S.C. 1395hh |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Elise Barringer Health Insurance Specialist Department of Health and Human Services Centers for Medicare & Medicaid Services Center for Medicare, MS: C4-03-06, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-9222 Email: elise.barringer@cms.hhs.gov |